All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0722-YF353 | TS-IL15 SA Anti-Human NKG2DL scFv (NKG2D receptor) CD28-4-1BB-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-YF413 | TS-NKG2DL Anti-hCD3 and Anti-Human NKG2DL scFv (NKG2D receptor) CD28-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-NKG2DL Anti-hCD3 and (OKT3 scFv-NKG2D ECD)-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-YF473 | TS-NKG2DL Anti-hCD3 and Anti-Human NKG2DL scFv (NKG2D receptor) 4-1BB-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-NKG2DL Anti-hCD3 and (OKT3 scFv-NKG2D ECD)-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0722-YF533 | TS-NKG2DL Anti-hCD3 and Anti-Human NKG2DL scFv (NKG2D receptor) CD28-4-1BB-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-NKG2DL Anti-hCD3 and (OKT3 scFv-NKG2D ECD)-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0822-YF593 | Anti-Human NKG2DL (XW-593) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-593 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF594 | Anti-Human NKG2DL (XW-594) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-594 | Human | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF733 | Anti-Human NKG2DL (NKG2D receptor) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | NKG2D receptor | Human | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1513 | Anti-Human NKG2DL (XW-593) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-593 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1514 | Anti-Human NKG2DL (XW-594) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-594 | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1653 | Anti-Human NKG2DL (NKG2D receptor) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | NKG2D receptor | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2433 | Anti-Human NKG2DL (XW-593) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-593 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2434 | Anti-Human NKG2DL (XW-594) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-594 | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2573 | Anti-Human NKG2DL (NKG2D receptor) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | NKG2D receptor | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF8981 | TS-Fluc Anti-Human NKG2DL scFv (NKG2D receptor) 41BB-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-Fluc-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9390 | TS-Fluc Anti-Human NKG2DL scFv (NKG2D receptor) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-Fluc-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10208 | TS-IL15 SA Anti-Human NKG2DL scFv (NKG2D receptor) 41BB-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-IL15 SA-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10617 | TS-IL15 SA Anti-Human NKG2DL scFv (NKG2D receptor) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | NKG2D receptor | Human | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0123-ZP786 | Anti-NKG2DL (trNKG2D) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | trNKG2D | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-ZP786 | Anti-NKG2DL (trNKG2D scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | trNKG2D | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0923-LX109 | Anti-hNKG2DL (CD28-41BB-CD3ζ) CAR-duplex CTLA4 pCDCAR1 Vector | Human | X9X-78 | scFv-CD28-41BB-CD3ζ-duplex CTLA4 | Lentiviral vector | T cell | CAR-T |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION